CVE-2023-47797

Liferay Portal cross-site scripting (XSS)

9.6 CRITICALEPSS 0.65%

Published17 Nov 2023

Description

Reflected cross-site scripting (XSS) vulnerability on a content page’s edit page in Liferay Portal 7.4.3.94 through 7.4.3.95 allows remote attackers to inject arbitrary web script or HTML via the `p_l_back_url_title` parameter.

CVSS 3.1 breakdown

Attack vectorNetwork

Attack complexityLow

Privileges requiredNone

User interactionRequired

ScopeChanged

ConfidentialityHigh

IntegrityHigh

AvailabilityHigh

CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:H/I:H/A:H

Affected products

Liferay Portal≥ 7.4.3.94 ≤ 7.4.3.95

Remediation

No fixed version is recorded in the NVD data. Check the vendor advisory for the latest guidance.

Frequently asked

Is CVE-2023-47797 being actively exploited?

CVE-2023-47797 is not in the CISA KEV catalog. Its EPSS exploit probability is 0.65%.

How severe is CVE-2023-47797?

CVE-2023-47797 has a CVSS 3.1 base score of 9.6, rated critical. EPSS estimates a 0.65% probability of exploitation.

Which products are affected by CVE-2023-47797?

Affected products include Liferay Portal.

How do I fix CVE-2023-47797?

Apply the vendor's patch or advisory guidance, then verify no affected versions remain across your devices.

How Secuno handles this

Secuno correlates vulnerabilities like CVE-2023-47797 against the real software inventory on every managed device, as each hourly inventory arrives. Rather than a static severity, each match is scored in context: exploit availability, EPSS, the asset's exposure, and business criticality decide where it lands in the queue. If an affected version is present anywhere across your portfolio, it surfaces automatically with a prioritised remediation path.

See how prioritisation works Book a demo

Data from the NVD, CISA KEV catalog and FIRST EPSS. CVSS 3.1 base score shown where available.